The DeltaF508 cystic fibrosis mutation impairs domain-domain interactions and arrests post-translational folding of CFTR
- PMID: 15619635
- DOI: 10.1038/nsmb882
The DeltaF508 cystic fibrosis mutation impairs domain-domain interactions and arrests post-translational folding of CFTR
Abstract
Misfolding accounts for the endoplasmic reticulum-associated degradation of mutant cystic fibrosis transmembrane conductance regulators (CFTRs), including deletion of Phe508 (DeltaF508) in the nucleotide-binding domain 1 (NBD1). To study the role of Phe508, the de novo folding and stability of NBD1, NBD2 and CFTR were compared in conjunction with mutagenesis of Phe508. DeltaF508 and amino acid replacements that prevented CFTR folding disrupted the NBD2 fold and its native interaction with NBD1. DeltaF508 caused limited alteration in NBD1 conformation. Whereas nonpolar and some aliphatic residues were permissive, charged residues and glycine compromised the post-translational folding and stability of NBD2 and CFTR. The results suggest that hydrophobic side chain interactions of Phe508 are required for vectorial folding of NBD2 and the domain-domain assembly of CFTR, representing a combined co- and post-translational folding mechanism that may be used by other multidomain membrane proteins.
Similar articles
-
Domain interdependence in the biosynthetic assembly of CFTR.J Mol Biol. 2007 Jan 26;365(4):981-94. doi: 10.1016/j.jmb.2006.10.086. Epub 2006 Nov 10. J Mol Biol. 2007. PMID: 17113596
-
Correctors enhance maturation of DeltaF508 CFTR by promoting interactions between the two halves of the molecule.Biochemistry. 2009 Oct 20;48(41):9882-90. doi: 10.1021/bi9004842. Biochemistry. 2009. PMID: 19761259
-
Deletion of Phe508 in the first nucleotide-binding domain of the cystic fibrosis transmembrane conductance regulator increases its affinity for the heat shock cognate 70 chaperone.FEBS J. 2009 Dec;276(23):7097-109. doi: 10.1111/j.1742-4658.2009.07421.x. Epub 2009 Oct 29. FEBS J. 2009. PMID: 19878303
-
Misfolding of the cystic fibrosis transmembrane conductance regulator and disease.Biochemistry. 2008 Feb 12;47(6):1465-73. doi: 10.1021/bi702209s. Epub 2008 Jan 15. Biochemistry. 2008. PMID: 18193900 Review.
-
Pharmacological induction of CFTR function in patients with cystic fibrosis: mutation-specific therapy.Pediatr Pulmonol. 2005 Sep;40(3):183-96. doi: 10.1002/ppul.20200. Pediatr Pulmonol. 2005. PMID: 15880796 Review.
Cited by
-
CFTR trafficking mutations disrupt cotranslational protein folding by targeting biosynthetic intermediates.Nat Commun. 2020 Aug 26;11(1):4258. doi: 10.1038/s41467-020-18101-8. Nat Commun. 2020. PMID: 32848127 Free PMC article.
-
Functional Rescue of F508del-CFTR Using Small Molecule Correctors.Front Pharmacol. 2012 Sep 26;3:160. doi: 10.3389/fphar.2012.00160. eCollection 2012. Front Pharmacol. 2012. PMID: 23055971 Free PMC article.
-
Revertant mutants G550E and 4RK rescue cystic fibrosis mutants in the first nucleotide-binding domain of CFTR by different mechanisms.Proc Natl Acad Sci U S A. 2006 Nov 21;103(47):17891-6. doi: 10.1073/pnas.0608312103. Epub 2006 Nov 10. Proc Natl Acad Sci U S A. 2006. PMID: 17098864 Free PMC article.
-
Restoration of domain folding and interdomain assembly by second-site suppressors of the DeltaF508 mutation in CFTR.FASEB J. 2010 Aug;24(8):3103-12. doi: 10.1096/fj.09-141788. Epub 2010 Mar 16. FASEB J. 2010. PMID: 20233947 Free PMC article.
-
Pharmacological chaperoning: a primer on mechanism and pharmacology.Pharmacol Res. 2014 May;83:10-9. doi: 10.1016/j.phrs.2014.01.005. Epub 2014 Feb 14. Pharmacol Res. 2014. PMID: 24530489 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical